Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 109
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02002130 | The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes | ||
| NCT00214552 | Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. | ||
| NCT06066346 | A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy | ||
| NCT06549634 | Biomarkers of AKI in Patients Receiving Daratumumab | ||
| NCT07110844 | Teclistamab-Daratumumab in AL Amyloidosis | ||
| NCT05619536 | Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects | ||
| NCT05546242 | Improving HIV-1 Control in Africa with Long Acting Antiretrovirals | ||
| NCT03503344 | Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer | ||
| NCT02172872 | "InDACtion" vs "3+7" Induction in AML | ||
| NCT02929745 | Single Cell Genomics of Psoriatic Skin | ||
| NCT01376401 | Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma | ||
| NCT03899155 | Pan Tumor Rollover Study | ||
| NCT03283917 | Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis | ||
| NCT03586570 | A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects | ||
| NCT03475628 | Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma | ||
| NCT05486481 | Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) | ||
| NCT04089345 | Stelara fOr ChRonic AntibioTic rEfractory pouchitiS | ||
| NCT03655223 | Early Check: Expanded Screening in Newborns | ||
| NCT02471196 | Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease | ||
| NCT05971602 | Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis | ||
| NCT03823924 | Changes in Body Composition Under Ustekinumab in PsA | ||
| NCT00140426 | A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa | ||
| NCT04371380 | Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants | ||
| NCT05285137 | Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects | ||
| NCT01837862 | A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | ||
| NCT00222807 | Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus | ||
| NCT06816992 | ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT02772588 | AASUR in High Risk Prostate Cancer | ||
| NCT01751451 | 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy | ||
| NCT03236428 | Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma | ||
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | ||
| NCT04399551 | A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries | ||
| NCT01717053 | Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | ||
| NCT06083922 | A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) | ||
| NCT04116606 | Antidepressant Trial With P2X7 Antagonist JNJ-54175446 | ||
| NCT05523089 | The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults | ||
| NCT02422797 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2) | ||
| NCT02342249 | Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects | ||
| NCT04407442 | Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab | ||
| NCT00001018 | A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea | ||
| NCT03404635 | Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism | ||
| NCT00855413 | HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine | ||
| NCT00167154 | Risperidone and Suicidality in Major Depressive Disorder | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT05304858 | Tumor Microenvironment Analysis of Prostate Cancer Metastasis | ||
| NCT02438631 | Placental Passage and Disposition of Drugs: A Physiology-based Approach | ||
| NCT03093272 | A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer | ||
| NCT02987829 | Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients | ||
| NCT02120352 | A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects |
